168 related articles for article (PubMed ID: 33151123)
1. Proteogenomic examination of esophageal squamous cell carcinoma (ESCC): new lines of inquiry.
Dagamajalu S; Vijayakumar M; Shetty R; Rex DAB; Narayana Kotimoole C; Prasad TSK
Expert Rev Proteomics; 2020 Sep; 17(9):649-662. PubMed ID: 33151123
[No Abstract] [Full Text] [Related]
2. An overview of esophageal squamous cell carcinoma proteomics.
Qi YJ; Chao WX; Chiu JF
J Proteomics; 2012 Jun; 75(11):3129-37. PubMed ID: 22564818
[TBL] [Abstract][Full Text] [Related]
3. Mass Spectrometry for Biomarkers Discovery in Esophageal Squamous Cell Carcinoma.
Islam F; Gopalan V; Lam AK
Methods Mol Biol; 2020; 2129():259-268. PubMed ID: 32056183
[TBL] [Abstract][Full Text] [Related]
4. SILAC-based quantitative proteomic approach to identify potential biomarkers from the esophageal squamous cell carcinoma secretome.
Kashyap MK; Harsha HC; Renuse S; Pawar H; Sahasrabuddhe NA; Kim MS; Marimuthu A; Keerthikumar S; Muthusamy B; Kandasamy K; Subbannayya Y; Prasad TS; Mahmood R; Chaerkady R; Meltzer SJ; Kumar RV; Rustgi AK; Pandey A
Cancer Biol Ther; 2010 Oct; 10(8):796-810. PubMed ID: 20686364
[TBL] [Abstract][Full Text] [Related]
5. Using proteomic approach to identify tumor-associated proteins as biomarkers in human esophageal squamous cell carcinoma.
Zhang J; Wang K; Zhang J; Liu SS; Dai L; Zhang JY
J Proteome Res; 2011 Jun; 10(6):2863-72. PubMed ID: 21517111
[TBL] [Abstract][Full Text] [Related]
6. Multi-omics characterization of esophageal squamous cell carcinoma identifies molecular subtypes and therapeutic targets.
Zhao D; Guo Y; Wei H; Jia X; Zhi Y; He G; Nie W; Huang L; Wang P; Laster KV; Liu Z; Wang J; Lee MH; Dong Z; Liu K
JCI Insight; 2024 Apr; 9(10):. PubMed ID: 38652547
[TBL] [Abstract][Full Text] [Related]
7. Tissue protein biomarker candidates to predict progression of esophageal squamous cell carcinoma and precancerous lesions.
Wang M; Smith JS; Wei WQ
Ann N Y Acad Sci; 2018 Dec; 1434(1):59-69. PubMed ID: 29882970
[TBL] [Abstract][Full Text] [Related]
8. Proteomic profiling of plasma exosomes reveals CD82 involvement in the development of esophageal squamous cell carcinoma.
Yang L; Salai A; Sun X; Liu Q; Liu T; Zhang Q; Tuerxun A; Tan Y; Zheng S; Lu X
J Proteomics; 2022 Aug; 265():104662. PubMed ID: 35728771
[TBL] [Abstract][Full Text] [Related]
9. Identification of potential plasma biomarkers for esophageal squamous cell carcinoma by a proteomic method.
Zhao J; Fan YX; Yang Y; Liu DL; Wu K; Wen FB; Zhang CY; Zhu DY; Zhao S
Int J Clin Exp Pathol; 2015; 8(2):1535-44. PubMed ID: 25973038
[TBL] [Abstract][Full Text] [Related]
10. Target Score-A Proteomics Data Selection Tool Applied to Esophageal Cancer Identifies GLUT1-Sialyl Tn Glycoforms as Biomarkers of Cancer Aggressiveness.
Cotton S; Ferreira D; Soares J; Peixoto A; Relvas-Santos M; Azevedo R; Piairo P; Diéguez L; Palmeira C; Lima L; Silva AMN; Lara Santos L; Ferreira JA
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562270
[TBL] [Abstract][Full Text] [Related]
11. iTRAQ-Based Quantitative Proteomic Analyses of High Grade Esophageal Squamous Intraepithelial Neoplasia.
Zhang J; Zhi C; Zhen F; Yuan X; Jiao C; Zhu H; Zhu H; Feng Y
Proteomics Clin Appl; 2017 Dec; 11(11-12):. PubMed ID: 28816019
[TBL] [Abstract][Full Text] [Related]
12. Integrative proteogenomic characterization of early esophageal cancer.
Li L; Jiang D; Zhang Q; Liu H; Xu F; Guo C; Qin Z; Wang H; Feng J; Liu Y; Chen W; Zhang X; Bai L; Tian S; Tan S; Xu C; Song Q; Liu Y; Zhong Y; Chen T; Zhou P; Zhao JY; Hou Y; Ding C
Nat Commun; 2023 Mar; 14(1):1666. PubMed ID: 36966136
[TBL] [Abstract][Full Text] [Related]
13. Tubulin beta chain, filamin A alpha isoform 1, and cytochrome b-c1 complex subunit 1 as serological diagnostic biomarkers of esophageal squamous cell carcinoma: a proteomics study.
Fan NJ; Gao CF; Wang XL
OMICS; 2013 Apr; 17(4):215-23. PubMed ID: 23496306
[TBL] [Abstract][Full Text] [Related]
14. EIF3H promotes aggressiveness of esophageal squamous cell carcinoma by modulating Snail stability.
Guo X; Zhu R; Luo A; Zhou H; Ding F; Yang H; Liu Z
J Exp Clin Cancer Res; 2020 Aug; 39(1):175. PubMed ID: 32867821
[TBL] [Abstract][Full Text] [Related]
15. ORAOV1 overexpression in esophageal squamous cell carcinoma and esophageal dysplasia: a possible biomarker of progression and poor prognosis in esophageal carcinoma.
Li M; Cui X; Shen Y; Dong H; Liang W; Chen Y; Hu J; Li S; Kong J; Li H; Zhao J; Li F
Hum Pathol; 2015 May; 46(5):707-15. PubMed ID: 25732110
[TBL] [Abstract][Full Text] [Related]
16. ESCC ATLAS: A population wide compendium of biomarkers for Esophageal Squamous Cell Carcinoma.
Tungekar A; Mandarthi S; Mandaviya PR; Gadekar VP; Tantry A; Kotian S; Reddy J; Prabha D; Bhat S; Sahay S; Mascarenhas R; Badkillaya RR; Nagasampige MK; Yelnadu M; Pawar H; Hebbar P; Kashyap MK
Sci Rep; 2018 Aug; 8(1):12715. PubMed ID: 30143675
[TBL] [Abstract][Full Text] [Related]
17. Etiology, cancer stem cells and potential diagnostic biomarkers for esophageal cancer.
Liu K; Zhao T; Wang J; Chen Y; Zhang R; Lan X; Que J
Cancer Lett; 2019 Aug; 458():21-28. PubMed ID: 31125642
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive bioinformatics analysis identifies lncRNA HCG22 as a migration inhibitor in esophageal squamous cell carcinoma.
Li X; Xiao X; Chang R; Zhang C
J Cell Biochem; 2020 Jan; 121(1):468-481. PubMed ID: 31236983
[TBL] [Abstract][Full Text] [Related]
19. Ubiquitin-specific peptidase 46 promotes tumor metastasis through stabilizing ENO1 in human esophageal squamous cell carcinoma.
Tian M; Zhu R; Ding F; Liu Z
Exp Cell Res; 2020 Oct; 395(1):112188. PubMed ID: 32707136
[TBL] [Abstract][Full Text] [Related]
20. High expression of HLA-DQA1 predicts poor outcome in patients with esophageal squamous cell carcinoma in Northern China.
Shen FF; Pan Y; Li JZ; Zhao F; Yang HJ; Li JK; Gao ZW; Su JF; Duan LJ; Lun SM; Zhang P; Tian LQ; Sun G; Huang D; Cao YT; Zhou FY
Medicine (Baltimore); 2019 Feb; 98(8):e14454. PubMed ID: 30813145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
